[Form 4] AUTOLIV INC Insider Trading Activity

Rhea-AI Filing Summary

Dumont Fabien reported acquisition or exercise transactions in this Form 4 filing.

Autoliv Inc. executive Fabien Dumont, EVP & Chief Technology Officer, reported multiple equity awards in the form of restricted stock units and performance-based restricted stock units tied to Autoliv common stock. All transactions are coded as grants or awards, not open-market purchases or sales.

The awards include performance-based RSUs from 2024 and 2025 that vest in a single installment after three one-year performance periods ending on December 31, 2026 and December 31, 2027, subject to committee certification of results. Additional time-based RSUs are scheduled to vest on February 20, 2027, February 20, 2028, and February 19, 2029. Each RSU represents a contingent right to receive one share of Autoliv common stock, and dividend equivalent rights can accrue as additional RSUs under the same vesting terms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dumont Fabien

(Last) (First) (Middle)

C/O AUTOLIV, INC.

KLARABERGSVIADUKTEN 70, SECTION D5

(Street)

STOCKHOLM SWEDEN SE-111 64

(City) (State) (Zip)

SWEDEN

(Country)

2. Issuer Name and Ticker or Trading Symbol
AUTOLIV INC [ ALV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance-Based Restricted Stock Units (2024 Grant)	(1)	03/19/2026		A(2)		3.8251		(3)	(3)	Common Stock	3.8251	$0	451.1361	D
Performance-Based Restricted Stock Units (2025 Grant)	(1)	03/19/2026		A(2)		5.7512		(4)	(4)	Common Stock	5.7512	$0	678.3106	D
Restricted Stock Unit	(1)	03/19/2026		A(2)		1.6072		02/20/2027	02/20/2027	Common Stock	1.6072	$0	189.553	D
Restricted Stock Unit	(1)	03/19/2026		A(2)		4.4583		02/20/2028	02/20/2028	Common Stock	4.4583	$0	525.8221	D
Restricted Stock Unit	(1)	03/19/2026		A(2)		3.8395		02/19/2029	02/19/2029	Common Stock	3.8395	$0	452.8395	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock.

2. Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs.

3. The performance-based RSUs, as adjusted if necessary, vest and convert to shares in one installment after the completion of the third one-year performance period ending December 31, 2026 and the Leadership Development and Compensation Committee's certification of the level of achievement of the applicable performance objectives.

4. The performance-based RSUs, as adjusted if necessary, vest and convert to shares in one installment after the completion of the third one-year performance period ending December 31, 2027 and the Leadership Development and Compensation Committee's certification of the level of achievement of the applicable performance objectives.

	Brian Kelly by POA from Fabien Dumont	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)